Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease Paris, May 28, 2026. The…
LOS ANGELES, May 20, 2026 /PRNewswire/ -- The Internet Corporation for Assigned Names and Numbers (ICANN) today announced that it…
Senior exhibitions leader to drive growth, expand WTE Miami, and bring high-potential event IPs to India MUMBAI, India and MIAMI,…
ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase 4 study…
CAIRO, March 30, 2026 /PRNewswire/ -- H.E. Sherif Fathy, Minister of Tourism and Antiquities, confirmed that the government's recently announced…
Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in…
Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director Paris, March 5, 2026. The Board of Directors of Sanofi has…
Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that…
Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease Recommendation supported by safety and efficacy…
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on…